FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News FDA Sends Warning Letters to Multiple Companies for Illegally Selling Adulterated Dietary Supplements FDA The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide FDA Warning Letter to Neil R. Feins, M.D. 2009 05 20 Circare Peptide Therapy in Boise Specialized Treatment for First Responders Blueline Wellness The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York